Breast Cancer Trial, Recruiting NCT06713161 Sponsor: Yunnan Cancer Hospital Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT06713161
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are between 18 and 75 years old
  • People who are female
  • People who have a lump or mass in the breast that doctors believe can be surgically removed
  • People who are considered a suitable candidate for surgery
  • People who are able to understand and agree to take part in the consent process

Who may not be able to join:

  • People who are unable to take part in the consent process
  • People who have medical reasons that make surgery unsafe, such as serious heart or lung conditions, or problems with blood clotting
  • People who have other conditions that the research team considers unsuitable for taking part in the study (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 86+18059766094

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Yunnan Cancer Hospital
Registry
ClinicalTrials.gov
Start date
1 September 2024
Est. completion
25 August 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Expression of the CXCR4 in the tumor; Uptake of the dye by the tissue(i.e tumor,metastatic SLN); False positive rates of the NIR-II probe (ICG-POL6326)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov